iPSCs have revealed clues about pathology and potential treatments: for example, iPSC-derived neurons from Rett syndrome patients show reduced synaptic puncta and decreased glutamatergic signalling, deficits rescued by insulin-like growth factor 1 (IGF1) application (Marchetto et al., 2010). This evidence concerns the gene IGF1 and atypical Rett syndrome.